Norcuron and Etomidate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Norcuron (vecuronium bromide) and Etomidate (etomidate). Common drug interactions include anxiety among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Norcuron and Etomidate. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Norcuron?

Norcuron has active ingredients of vecuronium bromide. eHealthMe is studying from 430 Norcuron users. Check the latest studies of Norcuron.

What is Etomidate?

Etomidate has active ingredients of etomidate. eHealthMe is studying from 2,496 Etomidate users. Check the latest studies of Etomidate.



On Jul, 09, 2026

22 people who take Norcuron and Etomidate together, and have interactions are studied.

Norcuron and Etomidate drug interactions.

What are the common drug interactions of Norcuron and Etomidate, by gender? *:

female:

  1. Anxiety
  2. Depression
  3. Septic shock (shock due to blood infection)
  4. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  5. Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
  6. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Emotional distress
  9. Fear
  10. Injury

male:

  1. Cardiac arrest
  2. Aspartate aminotransferase increased
  3. Renal tubular necrosis (death of kidney tubules)
  4. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  5. Acute respiratory distress syndrome
  6. Acute respiratory failure
  7. Agitation (state of anxiety or nervous excitement)
  8. Alanine aminotransferase increased
  9. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  10. Blood albumin decreased

What are the common drug interactions of Norcuron and Etomidate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Prothrombin time ratio decreased
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Blood pressure decreased
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  7. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  8. Disturbance in attention
  9. Haemophilus infection (bacterial infection by haemophilus influenzae)
  10. Haemorrhage (bleeding)

20-29:

  1. Septic shock (shock due to blood infection)
  2. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  3. Anxiety
  4. Depression
  5. Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
  6. Pneumonia

30-39:

n/a

40-49:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  2. Erythema (redness of the skin)
  3. Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls)

50-59:

  1. Anxiety
  2. Depression
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Emotional distress
  5. Fear
  6. Injury
  7. Multi-organ failure (multisystem organ failure)
  8. Nervousness
  9. Pain
  10. Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)

60+:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  2. Death
  3. Circulatory collapse
  4. Cytokine storm (over-protective immune response that can actually be fatal)
  5. Emotional distress
  6. Fear
  7. Glomerular filtration rate decreased
  8. Injury
  9. Multi-organ failure (multisystem organ failure)
  10. Pain

What are the existing conditions these people have? *

  1. Psychotic Disorder: 8 people, 36.36%
  2. Pneumonia: 8 people, 36.36%
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 8 people, 36.36%
  4. Depression: 8 people, 36.36%
  5. Agitation (state of anxiety or nervous excitement): 8 people, 36.36%
  6. General Anaesthesia: 4 people, 18.18%
  7. Post Procedural Pain: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Norcuron and Etomidate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Norcuron and Etomidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Norcuron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Etomidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Norcuron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Etomidate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vecuronium bromide and etomidate (the active ingredients of Norcuron and Etomidate, respectively), and Norcuron and Etomidate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: